The Texas Heart Institute Names Dr. Yaxin Wang as First Female Endowed Chair for Innovative Device & Engineering Applications
The Texas Heart Institute is proud to announce Yaxin Wang, PhD, as the John S. Dunn Endowed Chair in Innovative...
Darren G. Woodside
Research Social Delivers Dynamic Afternoon Focused on Collaborative Science
On November 20, 2024, The Texas Heart Institute (THI) held its first-ever Research Social, marking a significant shift from traditional...
7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...
Bringing Together the Best of Cardiovascular Science: The Texas Heart Institute Hosts 11th Annual IACS-NAS Meeting
Demonstrating its continued commitment to innovation in cardiovascular science and medicine, The Texas Heart Institute recently hosted the 11th Annual...
A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities
Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
A Beautiful Painting by THI Artist and Scientist Unveiled
Born in Berlin, Shahrzad Abbasi has always loved and appreciated art. At a very young age, she began painting and pursued formal...
The Texas Heart Institute Research Symposium: Cutting-Edge Innovations Driving Translational Clinical Care
HOUSTON (Oct. 27, 2023) — Renowned scientists and clinicians from The Texas Heart Institute gathered this week for its inspiring,...
Houston Supports The Texas Heart Institute in Style at The Post Oak
The Supper Club gala, held at the fabulous Post Oak Hotel, was a magical night about giving back and raising...
The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was...
NIH Awards The Texas Heart Institute $1.14 Million to Develop a Novel, First-in-Class Drug for Atherosclerotic Cardiovascular Disease
HOUSTON (Aug. 22, 2023) — The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI)...
Student Scholar Phong Tran Named ASAIO Student Design Competition Finalist
Society Recognizes IDEA Lab Student Scholars Two Years in a Row Phong Tran, a student scholar in The Texas Heart...
The Texas Heart Institute Biorepository Core Reaccredited by the College of American Pathologists
The Texas Heart Institute Biorepository and Biospecimen Profiling Core Laboratory has been reaccredited by the College of American Pathologists (CAP)...
